AI? Aye. Aye.
FDA is enhancing its ability to handle real-world evidence by training reviewers in data science via a curriculum on machine learning and artificial intelligence, said FDA Commissioner Scott Gottlieb.
Source: drugwonks.com Blog - Category: Pharmaceuticals Source Type: blogs
More News: Blogging | Learning | Pharmaceuticals | Science | Training | Universities & Medical Training